QMSMEDI QMS Medical Allied Services Q1 FY27 results (Apr–Jun 2026) and concall
QMS Medical Allied Services Limited reported a strong start to FY27 with significant year-on-year and sequential growth across key financial metrics, driven by its service and product businesses. The company successfully migrated to the NSE main board and saw robust performance in its Patient Service Programs and B2B health camps. Management maintained its full-year guidance, expressing confidence in continued growth and operational performance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 23.7%, net profit down 0.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33 | 39 | 42 | 42 | 41 +26% | 30 −25% | 39 −8% | 52 +24% |
| EBITDA | 5 | 5 | 8 | 6 | 6 +15% | 4 −29% | 4 −44% | 7 +11% |
| Net profit | 3 | 2 | 3 | 3 | 3 +1% | 1 −75% | 1 −79% | 3 −0% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
